The results suggested that miR-96 may activate the Akt pathway phosphorylation by targeting ARID2 to promote the proliferation of human degenerated NPCs, which may become a therapeutic target for IDD. The gene discussed is AKT1; the disease is intervertebral disk degenerative disorder.